4//SEC Filing
Jazz Pharmaceuticals plc 4
Accession 0001232524-15-000044
$JAZZCIK 0001232524operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:58 PM ET
Size
11.0 KB
Accession
0001232524-15-000044
Insider Transaction Report
Form 4
Tobias Jeffrey K
SVP of Research & Dev and CMO
Transactions
- Award
Ordinary Shares
2015-02-26+5,755→ 40,818 total - Award
Non-Qualified Stock Option (right to buy)
2015-02-26+14,430→ 14,430 totalExercise: $175.19Exp: 2025-02-25→ Ordinary Shares (14,430 underlying) - Tax Payment
Ordinary Shares
2015-02-27$170.09/sh−704$119,743→ 40,114 total - Award
Incentive Stock Option (right to buy)
2015-02-26+570→ 570 totalExercise: $175.19Exp: 2025-02-25→ Ordinary Shares (570 underlying)
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in four equal annual installments on the anniversary of the grant date, February 26, 2015.
- [F2]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
- [F3]These two options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these two options vest over four years measured from the grant date, February 26, 2015, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001232524
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:58 PM ET
- Size
- 11.0 KB